Stay updated with breaking news from Leadcare Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands
BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands
Magellan Diagnostics admits that it misled customers and the FDA about a device malfunction that produced inaccurately low results in lead level blood tests for potentially tens of thousands of children and other patients.
A Massachusetts-based company will plead guilty to resolve allegations that it knowingly concealed a flaw in its lead blood tests that caused numerous inaccurate results.
Magellan Diagnostics, Inc. pleaded guilty to criminal charges for concealing a device malfunction. They now owe more than $42 million in fines.